FDA to Address ‘Narrow’ Labeling of In Vitro Companion Devices for Cancer Drugs

Drug Industry Daily
A A
The way in vitro companion diagnostics for cancer drugs are labeled sometimes presents a challenge for oncology care, Commissioner Scott Gottlieb said Thursday in announcing new guidance to tackle the problem.

To View This Article:

Login

Subscribe To Drug Industry Daily